Steward Partners Investment Advisory’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-185
Closed -$1.06K 3340
2023
Q1
$1.06K Buy
+185
New +$1.06K ﹤0.01% 3115
2022
Q4
Sell
-185
Closed -$4K 3397
2022
Q3
$4K Hold
185
﹤0.01% 2844
2022
Q2
$5K Sell
185
-90
-33% -$2.43K ﹤0.01% 2764
2022
Q1
$11K Buy
275
+160
+139% +$6.4K ﹤0.01% 2611
2021
Q4
$7K Buy
115
+25
+28% +$1.52K ﹤0.01% 2721
2021
Q3
$5K Buy
+90
New +$5K ﹤0.01% 2800